Medicine

A. Maloberti, C. Giannattasio, M. Bombelli, G. Desideri, A. Cicero, M. Muiesan, E. Rosei, M. Salvetti, A. Ungar, G. Rivasi, R. Pontremoli, F. Viazzi, R. Facchetti, C. Ferri, B. Bernardino, F. Galletti, L. D’elia, P. Palatini, E. Casiglia, V. Tikhonoff, C. Barbagallo, P. Verdecchia, S. Masi, F. Mallamaci, M. Cirillo, M. Rattazzi, P. Pauletto, P. Cirillo, L. Gesualdo, A. Mazza, M. Volpe, G. Tocci, G. Iaccarino, P. Nazzaro, L. Lippa, G. Parati, R. Dell'Oro, F. Quarti-Trevano, G. Grassi, A. Virdis, C. Borghi, W. G. O. C. A. I. S. S. O. Hypertension

2020.3.10High Blood Pressure & Cardiovascular Prevention

DOI: 10.1007/s40292-020-00368-z

Resumen de tlooto

The Uric acid Right for heArt Health project is designed to define the level of uricemia above which the independent risk of CV disease may increase in a significantly manner, and the first results obtained are summarized and the further planned analysis is described.

Resumen

El resumen no está disponible.

Formato de cita

MALOBERTI, A., et al. Hyperuricemia and risk of cardiovascular outcomes: The experience of the URRAH (uric acid right for heart health) project. High Blood Pressure & Cardiovascular Prevention, 2020, 27: 121–128.